 If the disease responds to treatment with either ruxolitinib or dasatinib alone, you will continue to receive that drug by itself. That first cycle of therapy will be called Cycle 0. Your next cycle of dasatinib or ruxolitinib alone will continue to be called Cycle 0. Once you move to intensive chemotherapy described below, that first cycle will be called Cycle 1. 